Second-generation HIV microbicides: Continued development of griffithsin
Authors:
- 14 April 2009
- journal article
- editorial
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (15) , 6029-6030
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide componentProceedings of the National Academy of Sciences, 2009
- Whither or Wither Microbicides?Science, 2008
- Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical studyProceedings of the National Academy of Sciences, 2008
- Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical MicrobicidesAntimicrobial Agents and Chemotherapy, 2008
- Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti‐HIV microbicideJournal of Medical Primatology, 2007
- Production of a monoclonal antibody in plants with a humanized N‐glycosylation patternPlant Biotechnology Journal, 2007
- Monoclonal antibodies from plants: A new speed recordProceedings of the National Academy of Sciences, 2006
- Magnifection?a new platform for expressing recombinant vaccines in plantsVaccine, 2005
- Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.Journal of Biological Chemistry, 2005
- Sexually Transmitted Diseases and the Increased Risk for HIV Transmission: Implications for Cost-Effectiveness Analyses of Sexually Transmitted Disease Prevention InterventionsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000